Replies to post #19428 on RespireRx Pharmaceuticals Inc (RSPI)

[meixatech]

The fact of the matter is that Stoll would not be presenting if he did not have supportive data. No effect would have generated a pr indicating such as soon as it became apparent. We are past the negative scenario.

[gfp927z]

Aiming, I'm figuring the initial upside is in the $2.00-2.25 range, though it will depend on the strength of the RD-2 results tomorrow. Then the upside with an RD pharma deal is probably in the $3.00-4.00 range. Along the way, should someone step forward with a buyout offer, we could get $5 or better.

I'm considering holding onto a good portion of my position for the RD-1 results in several weeks, and then the RD pharma deal, but will stay in flexible mode :o)